Robotic Partial Nephrectomy
Robotic Partial Nephrectomy - Related Videos
08:34
Robot-assisted Partial Splenectomy
0 Views •
2026
This protocol describes a robot-assisted partial splenectomy for a benign splenic tumor. The robotic approach optimizes spleen preservation by enhancing surgical precision, minimizing blood loss, and improving postoperative outcomes. Key surgical steps include meticulous splenic hilum dissection, selective vascular ligation, intraoperative ultrasonography, and controlled parenchymal transection.
11:19
Robotic Myotomy and Partial Fundoplication for Achalasia
0 Views •
2023
Surgical myotomy with a partial fundoplication may be used in selected patients as a definitive treatment for achalasia. This article provides a step-by-step description of a robotic myotomy and partial fundoplication in a 32-year-old patient with megaesophagus.
10:41
Robotic D3 Partial Duodenal Resection with Primary Side-to-Side Anastomosis
0 Views •
2023
This protocol presents a case of a robotic partial duodenal resection with primary side-to-side duodeno-jejunal reconstruction in a patient with a 5 cm duodenal stenosis. This is done at the third duodenal segment (D3) after an endoscopic mucosal resection (EMR) for a duodenal polyp.
07:17
Single Port Donor Nephrectomy
0 Views •
Cited by 6 •
2011
Single port laparoscopic surgery is changing the standard of care in surgical care like nothing since the laparoscopic technique was introduced 20 years ago. We present out technique of single port donor nephrectomy using the Gelpoint device. We have successfully performed this surgery in 100 patients.
07:52
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
0 Views •
Cited by 41 •
2017
This manuscript provides a detailed two-step surgical procedure to perform mouse 5/6th partial nephrectomy (PNx) with pole ligation. Four weeks after surgery, in comparison with sham-operated mice, the PNx mice developed impaired renal function, anemia, cardiac hypertrophy, cardiac fibrosis, and decreased heart systolic and diastolic function.
FAQs
Preserving functioning kidney tissue supports the nephron-sparing objective of the operation and may help maintain renal function compared with removing the entire kidney. This goal shapes how the surgeon approaches the tumor, limits unnecessary tissue removal, and balances cancer treatment with preservation of the remaining kidney. The approach is therefore especially relevant when treatment planning must consider both tumor control and kidney function.
The robotic platform gives the surgeon control of instruments through small abdominal incisions while providing a magnified three-dimensional view. That visualization supports careful dissection of the renal mass, and the controlled instruments help the surgeon manage bleeding and close the remaining kidney tissue. These capabilities connect minimally invasive access with the precision required for nephron-sparing cancer surgery.
Robotic partial nephrectomy is used for selected localized renal tumors rather than every kidney tumor. Patient selection depends on whether the tumor can be removed while leaving useful healthy kidney tissue behind. This assessment links the tumor's localized status with the feasibility of a nephron-sparing operation and helps clinicians choose between partial removal and removal of the entire kidney.
The operation progresses through several connected tasks: the surgeon accesses the kidney through small abdominal incisions, identifies and dissects the tumor using magnified three-dimensional visualization, controls bleeding during removal, and closes the remaining kidney tissue. Together, these steps address the procedure's two central demands, treating the renal mass while preserving as much healthy kidney tissue as possible.
The surgeon must remove the renal tumor while avoiding unnecessary loss of surrounding healthy tissue. At the same time, bleeding must be controlled and the remaining kidney tissue must be closed securely. This balance determines whether the procedure achieves both of its principal aims: addressing localized cancer and retaining kidney tissue that can contribute to postoperative renal function.
This approach is relevant when clinicians evaluate treatment for a selected localized renal tumor and must weigh cancer treatment against preservation of kidney function. It informs preoperative planning, operative strategy, and postoperative care. Its medical importance extends beyond the surgical technique because the choice of nephron-sparing treatment can affect how much functioning kidney tissue remains after tumor removal.